Hall Ashley has filed 13 insider transactions across 2 companies since August 2023.
Most recent transaction: a grant/award of 47706 shares of Structure Therapeutics Inc. ($GPCR) on March 19, 2026.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 19, 2026 | Structure Therapeutics Inc. | $GPCR | Hall Ashley | Chief Development Officer | A | Ordinary Shares | 47706 | $0.00 | 155,187.0000 | 177,596,000 | 44.39% | 0.03% |
| March 19, 2026 | Structure Therapeutics Inc. | $GPCR | Hall Ashley | Chief Development Officer | A | Employee Stock Option (right to buy) | 59073 | $0.00 | 59,073.0000 | 177,596,000 | 9999.99% | 0.03% |
| Nov. 20, 2025 | Structure Therapeutics Inc. | $GPCR | Hall Ashley | Chief Development Officer | A | American Depositary Shares | 237 | $0.00 | 462.0000 | 175,469,000 | 105.33% | 0.00% |
| March 3, 2026 | Structure Therapeutics Inc. | $GPCR | Hall Ashley | Chief Development Officer | F | Ordinary Shares | 4836 | $20.99 | 107,481.0000 | 177,596,000 | 4.31% | 0.00% |
| May 20, 2025 | Structure Therapeutics Inc. | $GPCR | Hall Ashley | Chief Development Officer | A | American Depositary Shares | 225 | $0.00 | 225.0000 | 172,051,000 | 9999.99% | 0.00% |
| Sept. 18, 2025 | Structure Therapeutics Inc. | $GPCR | Hall Ashley | Chief Development Officer | F | Ordinary Shares | 6021 | $7.74 | 112,317.0000 | 172,351,000 | 5.09% | 0.00% |
| March 15, 2025 | Structure Therapeutics Inc. | $GPCR | Hall Ashley | Chief Development Officer | A | Ordinary Shares | 51048 | $0.00 | 118,338.0000 | 157,922,000 | 75.86% | 0.03% |
| March 15, 2025 | Structure Therapeutics Inc. | $GPCR | Hall Ashley | Chief Development Officer | A | Employee Stock Option (right to buy) | 124032 | $0.00 | 124,032.0000 | 157,922,000 | 9999.99% | 0.08% |
| Sept. 18, 2024 | Structure Therapeutics Inc. | $GPCR | Hall Ashley | Chief Development Officer | A | Ordinary Shares | 67290 | $0.00 | 67,290.0000 | 148,239,000 | 9999.99% | 0.05% |
| Sept. 18, 2024 | Structure Therapeutics Inc. | $GPCR | Hall Ashley | Chief Development Officer | A | Share option (right to buy) | 82890 | $0.00 | 82,890.0000 | 148,239,000 | 9999.99% | 0.06% |
| Aug. 28, 2023 | OnKure Therapeutics, Inc. | $OKUR | Hall Ashley | Chief Development Officer | S | Common Stock | 15625 | $6.28 | 39,600.0000 | 0 | 28.29% | 0.00% |
| Aug. 28, 2023 | OnKure Therapeutics, Inc. | $OKUR | Hall Ashley | Chief Development Officer | M | Common Stock | 15625 | $1.80 | 55,225.0000 | 0 | 39.46% | 0.00% |
| Aug. 28, 2023 | OnKure Therapeutics, Inc. | $OKUR | Hall Ashley | Chief Development Officer | M | Stock option (right to buy) | 15625 | $0.00 | 109,375.0000 | 0 | 12.50% | 0.00% |